Total results found = 10
May 19, 2022 – Worthing-based Rayner, a global innovator in cataract and refractive surgery solutions and the only UK manufacturer of intraocular lenses (IOLs), announced today that AEON, its surgery-focused premium eye drops are now available in one of the leading UK optician chains, Boots Opticians, with more than 500 branches across the UK. In the UK,
Worthing, United Kingdom. Leading ophthalmology company Rayner has today announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of experienced Ophthalmic Specialist Area Managers, focused on delivering the highest levels of service and support. Through this team, French ophthalmologists now
The key objective of the National Account Manager – OSD is to achieve AEON product listings and sales within Pharmacies, Pharmacy Retail Groups and Optical Retail Chains and to create awareness for the therapy and our portfolio amongst prescribing physicians in Germany and the DACH region. Managing and developing key accounts across the Germany you will need to be an accomplished strategic account manager experienced working with Pharmacies, Pharmacy Retail Groups and Pharmacy Wholesalers. Your territory will be Germany, but business development in Austria and Switzerland may be a developing task. You should anticipate extensive travel and will ideally be located in Central Germany. Rayner is a leading developer and manufacturer of ophthalmic implants and pharmaceuticals; it specialises in intraocular lenses (IOLs) and related products used in cataract and refractive surgery. Since the development of the first IOL, Rayner has continuously pioneered IOL design with a goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic solutions that respond to the expectations of our global customers to improve sight and quality of life for their patients.
AEON and Sulcoflex Trifocal Clinical Article Barsam A
FEBRUARY 22 2022 – Worthing, United Kingdom. Rayner, a global innovator in cataract and refractive surgery, announced today that it has agreed a development partnership with Wolffsohn Research Ltd to accelerate the development of its Digital Health platform. Rayner launched RayPRO, a digital platform to collect patient reported outcomes (PRO), in 2019 and has since collected data
PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE USING THIS SITE This website www.staging.rayner.com (“the Site”) is produced and operated by Rayner Intraocular Lenses Limited (“Rayner”). These Terms of Use contain important information and set out your rights and responsibilities as a user of this website. 1. Purpose and Effect These Terms of Use are legally binding
AEON|cataract surgery|dry eye disease|Sulcoflex Trifocal|Tear film Clinical Article Barsam A
AEON|Benitez-del-Castillo|Cochener-Lamard|cross-linking|drops|dry eye|dry eye disease|dry eye drops|Guell|Hjortdal|hyaluronic acid|Koppen|ocular surface|ocular surface disease Clinical Article Guell J, Cochener-Lamard B, Koppen C, Benitez-del-Castillo JM, Hjortdal J
AEON|Alibrandi|Aragona|Calapai|cross-linking|drops|dry eye|dry eye disease|dry eye drops|hyaluronic acid|Mannucci|ocular surface|Postorino|Puzzolo|Rania Peer Review Publication Postorino E, Rania L, Aragona E, Mannucci C, Alibrandi A, Calapai G, Puzzolo D, Aragona P
AEON|cross-linking|drops|dry eye|dry eye disease|dry eye drops|hyaluronic acid|Mann|ocular surface|Williams Peer Review Publication Williams DL, Mann BK